I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| mast cell | 11 studies | 34% ± 11% | |
| oligodendrocyte precursor cell | 10 studies | 32% ± 9% | |
| GABAergic neuron | 9 studies | 48% ± 22% | |
| glutamatergic neuron | 9 studies | 45% ± 24% | |
| astrocyte | 9 studies | 25% ± 10% | |
| dendritic cell | 7 studies | 23% ± 5% | |
| fibroblast | 7 studies | 25% ± 8% | |
| interneuron | 6 studies | 47% ± 17% | |
| T cell | 6 studies | 29% ± 8% | |
| pericyte | 6 studies | 20% ± 2% | |
| neuron | 4 studies | 26% ± 9% | |
| endothelial cell | 4 studies | 39% ± 17% | |
| microglial cell | 4 studies | 29% ± 6% | |
| CD4-positive, alpha-beta T cell | 4 studies | 32% ± 11% | |
| monocyte | 4 studies | 26% ± 3% | |
| natural killer cell | 4 studies | 34% ± 3% | |
| GABAergic interneuron | 3 studies | 37% ± 4% | |
| CD8-positive, alpha-beta T cell | 3 studies | 33% ± 8% | |
| GABAergic amacrine cell | 3 studies | 23% ± 5% | |
| glycinergic amacrine cell | 3 studies | 20% ± 2% | |
| ciliated cell | 3 studies | 26% ± 7% | |
| lymphocyte | 3 studies | 46% ± 12% |
